Ubs Asset Management Americas Inc Opti Nose, Inc. Transaction History

Ubs Asset Management Americas Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$3.58 - $7.44 $59,245 - $123,124	-16,549 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$3.49 - $9.2 $32,523 - $85,734	-9,319 Reduced 36.03%	16,549 $74,000
Q4 2019 Feb 14, 2020	SELL	$6.27 - $11.41 $1,304 - $2,373	-208 Reduced 0.8%	25,868 $238,000
Q3 2019 Nov 14, 2019	BUY	$4.75 - $8.38 $75,377 - $132,982	15,869 Added 155.47%	26,076 $182,000
Q2 2019 Aug 15, 2019	BUY	$6.4 - $10.94 $65,324 - $111,664	10,207 New	10,207 $0

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $33.3M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.